Skip to content

Clinical trials

Tachycardia, Ventricular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tachycardia, Ventricular Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20131
20151
20171
20192
20201
20211
20223
20232
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status5
Recruiting4
Terminated2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital3
Corxel Pharmaceuticals2
Shanghai MicroPort EP MedTech Co., Ltd.2
Sichuan Baili Pharmaceutical Co., Ltd.2
Tongji Hospital2
AstraZeneca1
Biotronik (Beijing) Medical Device Ltd.1
Boston Scientific Corporation1
Caijie Shen1
Medtronic Cardiac Rhythm and Heart Failure1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tachycardia, Ventricular23
Ventricular Fibrillation5
Atrial Fibrillation4
Ventricular Premature Complexes4
Atrial Flutter2
Death, Sudden, Cardiac2
Tachycardia2
Tachycardia, Supraventricular2
Arrhythmias, Cardiac1
Heart Failure1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.